Dosing of antidepressants in relation to body weight in children and adolescents with overweight

Overweight and obesity in children and adolescents may impact pharmacokinetics and drug exposure. The aim of the present study was to evaluate doses of antidepressants in relation to body weight in children. We used data from the BMI Epidemiology Study (BEST) Gothenburg cohort and the National Presc...

Full description

Saved in:
Bibliographic Details
Published in:International Journal of Obesity 2024-11
Main Authors: Izsak, Julia, Kimland, Elin E, Martikainen, Jari, Dahlén, Elin, Kindblom, Jenny M
Format: Article
Language:English
Subjects:
Endocrinology and Diabetes
Endokrinologi och diabetes
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c222t-bb6fa5f1cd170731f86270673de7e9e44a90933b2782cbbf002ed57bb0089cdc3
container_end_page
container_issue
container_start_page
container_title International Journal of Obesity
container_volume
creator Izsak, Julia
Kimland, Elin E
Martikainen, Jari
Dahlén, Elin
Kindblom, Jenny M
description Overweight and obesity in children and adolescents may impact pharmacokinetics and drug exposure. The aim of the present study was to evaluate doses of antidepressants in relation to body weight in children. We used data from the BMI Epidemiology Study (BEST) Gothenburg cohort and the National Prescribed Drug Register and included children and adolescents with a prescription of fluoxetine (n = 347) or sertraline (n = 733) and a weight measurement. For fluoxetine, individuals with overweight or obesity received slightly lower doses at first prescriptions, but not in iterated prescriptions. The weight-normalized dose was lower in individuals with overweight or obesity in first and iterated prescriptions, compared with normal weight (p 
doi_str_mv 10.1038/s41366-024-01677-2
format article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_gup_ub_gu_se_343980</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3128825494</sourcerecordid><originalsourceid>FETCH-LOGICAL-c222t-bb6fa5f1cd170731f86270673de7e9e44a90933b2782cbbf002ed57bb0089cdc3</originalsourceid><addsrcrecordid>eNo9kctu3DAMRYWiQTNJ-wNdFFp2o4R62LKXRZoXECCbZK1KFj2jwmO5kt1B_j6aOs2KBHnuBchLyFcOFxxkc5kVl3XNQCgGvNaaiQ9kw5WuWaVa_ZFsQIJmUNXVKTnL-TcAVBWIT-RUtpWSUrcb8utnzGHc0thTO87B45Qw59JmGkaacLBziCOdI3XRv9ADhu1uPq66XRh8wrHIPLU-Dpg7PMoOYd7R-BfTyn4mJ70dMn55q-fk-eb66eqOPTze3l_9eGCdEGJmztW9rXreea5BS943tdBQa-lRY4tK2RZaKZ3Qjeic6wEE-ko7B9C0ne_kOWGrbz7gtDgzpbC36cVEG8x2mUwZbReT0Ugl2wYK_33lpxT_LJhnsw_lgmGwI8YlG8lF04jySFVQsaJdijkn7N_NOZhjEmZNwpQkzL8kjCiib2_-i9ujf5f8f718BYu3hd0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128825494</pqid></control><display><type>article</type><title>Dosing of antidepressants in relation to body weight in children and adolescents with overweight</title><source>Springer Nature</source><source>Nature</source><source>Alma/SFX Local Collection</source><creator>Izsak, Julia ; Kimland, Elin E ; Martikainen, Jari ; Dahlén, Elin ; Kindblom, Jenny M</creator><creatorcontrib>Izsak, Julia ; Kimland, Elin E ; Martikainen, Jari ; Dahlén, Elin ; Kindblom, Jenny M</creatorcontrib><description>Overweight and obesity in children and adolescents may impact pharmacokinetics and drug exposure. The aim of the present study was to evaluate doses of antidepressants in relation to body weight in children. We used data from the BMI Epidemiology Study (BEST) Gothenburg cohort and the National Prescribed Drug Register and included children and adolescents with a prescription of fluoxetine (n = 347) or sertraline (n = 733) and a weight measurement. For fluoxetine, individuals with overweight or obesity received slightly lower doses at first prescriptions, but not in iterated prescriptions. The weight-normalized dose was lower in individuals with overweight or obesity in first and iterated prescriptions, compared with normal weight (p &lt; 0.01). For sertraline, there were no significant dose differences between individuals with overweight or obesity, compared with normal weight. However, pronounced differences were seen in dose per kilogram body weight in both first and iterated prescriptions (p &lt; 0.01). We conclude that the doses of fluoxetine and sertraline were essentially similar in individuals with overweight or obesity, but the weight-normalized doses were clearly lower. Given the ongoing obesity epidemic, larger studies addressing optimal dosing in individuals with elevated weight are warranted.</description><identifier>ISSN: 0307-0565</identifier><identifier>ISSN: 1476-5497</identifier><identifier>EISSN: 1476-5497</identifier><identifier>DOI: 10.1038/s41366-024-01677-2</identifier><identifier>PMID: 39543379</identifier><language>eng</language><publisher>England</publisher><subject>Endocrinology and Diabetes ; Endokrinologi och diabetes</subject><ispartof>International Journal of Obesity, 2024-11</ispartof><rights>2024. The Author(s).</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c222t-bb6fa5f1cd170731f86270673de7e9e44a90933b2782cbbf002ed57bb0089cdc3</cites><orcidid>0000-0003-4990-3545 ; 0000-0003-0366-1683 ; 0000-0001-8437-0639</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39543379$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://gup.ub.gu.se/publication/343980$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Izsak, Julia</creatorcontrib><creatorcontrib>Kimland, Elin E</creatorcontrib><creatorcontrib>Martikainen, Jari</creatorcontrib><creatorcontrib>Dahlén, Elin</creatorcontrib><creatorcontrib>Kindblom, Jenny M</creatorcontrib><title>Dosing of antidepressants in relation to body weight in children and adolescents with overweight</title><title>International Journal of Obesity</title><addtitle>Int J Obes (Lond)</addtitle><description>Overweight and obesity in children and adolescents may impact pharmacokinetics and drug exposure. The aim of the present study was to evaluate doses of antidepressants in relation to body weight in children. We used data from the BMI Epidemiology Study (BEST) Gothenburg cohort and the National Prescribed Drug Register and included children and adolescents with a prescription of fluoxetine (n = 347) or sertraline (n = 733) and a weight measurement. For fluoxetine, individuals with overweight or obesity received slightly lower doses at first prescriptions, but not in iterated prescriptions. The weight-normalized dose was lower in individuals with overweight or obesity in first and iterated prescriptions, compared with normal weight (p &lt; 0.01). For sertraline, there were no significant dose differences between individuals with overweight or obesity, compared with normal weight. However, pronounced differences were seen in dose per kilogram body weight in both first and iterated prescriptions (p &lt; 0.01). We conclude that the doses of fluoxetine and sertraline were essentially similar in individuals with overweight or obesity, but the weight-normalized doses were clearly lower. Given the ongoing obesity epidemic, larger studies addressing optimal dosing in individuals with elevated weight are warranted.</description><subject>Endocrinology and Diabetes</subject><subject>Endokrinologi och diabetes</subject><issn>0307-0565</issn><issn>1476-5497</issn><issn>1476-5497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kctu3DAMRYWiQTNJ-wNdFFp2o4R62LKXRZoXECCbZK1KFj2jwmO5kt1B_j6aOs2KBHnuBchLyFcOFxxkc5kVl3XNQCgGvNaaiQ9kw5WuWaVa_ZFsQIJmUNXVKTnL-TcAVBWIT-RUtpWSUrcb8utnzGHc0thTO87B45Qw59JmGkaacLBziCOdI3XRv9ADhu1uPq66XRh8wrHIPLU-Dpg7PMoOYd7R-BfTyn4mJ70dMn55q-fk-eb66eqOPTze3l_9eGCdEGJmztW9rXreea5BS943tdBQa-lRY4tK2RZaKZ3Qjeic6wEE-ko7B9C0ne_kOWGrbz7gtDgzpbC36cVEG8x2mUwZbReT0Ugl2wYK_33lpxT_LJhnsw_lgmGwI8YlG8lF04jySFVQsaJdijkn7N_NOZhjEmZNwpQkzL8kjCiib2_-i9ujf5f8f718BYu3hd0</recordid><startdate>20241114</startdate><enddate>20241114</enddate><creator>Izsak, Julia</creator><creator>Kimland, Elin E</creator><creator>Martikainen, Jari</creator><creator>Dahlén, Elin</creator><creator>Kindblom, Jenny M</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>F1U</scope><orcidid>https://orcid.org/0000-0003-4990-3545</orcidid><orcidid>https://orcid.org/0000-0003-0366-1683</orcidid><orcidid>https://orcid.org/0000-0001-8437-0639</orcidid></search><sort><creationdate>20241114</creationdate><title>Dosing of antidepressants in relation to body weight in children and adolescents with overweight</title><author>Izsak, Julia ; Kimland, Elin E ; Martikainen, Jari ; Dahlén, Elin ; Kindblom, Jenny M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c222t-bb6fa5f1cd170731f86270673de7e9e44a90933b2782cbbf002ed57bb0089cdc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Endocrinology and Diabetes</topic><topic>Endokrinologi och diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Izsak, Julia</creatorcontrib><creatorcontrib>Kimland, Elin E</creatorcontrib><creatorcontrib>Martikainen, Jari</creatorcontrib><creatorcontrib>Dahlén, Elin</creatorcontrib><creatorcontrib>Kindblom, Jenny M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Göteborgs universitet</collection><jtitle>International Journal of Obesity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Izsak, Julia</au><au>Kimland, Elin E</au><au>Martikainen, Jari</au><au>Dahlén, Elin</au><au>Kindblom, Jenny M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dosing of antidepressants in relation to body weight in children and adolescents with overweight</atitle><jtitle>International Journal of Obesity</jtitle><addtitle>Int J Obes (Lond)</addtitle><date>2024-11-14</date><risdate>2024</risdate><issn>0307-0565</issn><issn>1476-5497</issn><eissn>1476-5497</eissn><abstract>Overweight and obesity in children and adolescents may impact pharmacokinetics and drug exposure. The aim of the present study was to evaluate doses of antidepressants in relation to body weight in children. We used data from the BMI Epidemiology Study (BEST) Gothenburg cohort and the National Prescribed Drug Register and included children and adolescents with a prescription of fluoxetine (n = 347) or sertraline (n = 733) and a weight measurement. For fluoxetine, individuals with overweight or obesity received slightly lower doses at first prescriptions, but not in iterated prescriptions. The weight-normalized dose was lower in individuals with overweight or obesity in first and iterated prescriptions, compared with normal weight (p &lt; 0.01). For sertraline, there were no significant dose differences between individuals with overweight or obesity, compared with normal weight. However, pronounced differences were seen in dose per kilogram body weight in both first and iterated prescriptions (p &lt; 0.01). We conclude that the doses of fluoxetine and sertraline were essentially similar in individuals with overweight or obesity, but the weight-normalized doses were clearly lower. Given the ongoing obesity epidemic, larger studies addressing optimal dosing in individuals with elevated weight are warranted.</abstract><cop>England</cop><pmid>39543379</pmid><doi>10.1038/s41366-024-01677-2</doi><orcidid>https://orcid.org/0000-0003-4990-3545</orcidid><orcidid>https://orcid.org/0000-0003-0366-1683</orcidid><orcidid>https://orcid.org/0000-0001-8437-0639</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0307-0565
ispartof International Journal of Obesity, 2024-11
issn 0307-0565
1476-5497
1476-5497
language eng
recordid cdi_swepub_primary_oai_gup_ub_gu_se_343980
source Springer Nature; Nature; Alma/SFX Local Collection
subjects Endocrinology and Diabetes
Endokrinologi och diabetes
title Dosing of antidepressants in relation to body weight in children and adolescents with overweight
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A30%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dosing%20of%20antidepressants%20in%20relation%20to%20body%20weight%20in%20children%20and%20adolescents%20with%20overweight&rft.jtitle=International%20Journal%20of%20Obesity&rft.au=Izsak,%20Julia&rft.date=2024-11-14&rft.issn=0307-0565&rft.eissn=1476-5497&rft_id=info:doi/10.1038/s41366-024-01677-2&rft_dat=%3Cproquest_swepu%3E3128825494%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c222t-bb6fa5f1cd170731f86270673de7e9e44a90933b2782cbbf002ed57bb0089cdc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3128825494&rft_id=info:pmid/39543379&rfr_iscdi=true